On June 16, 2026, US health-solutions company WPS — an insurer with more than 80 years in the business — announced it had acquired Mavida Health, a virtual mental-health platform providing specialized therapy and psychiatry for women navigating reproductive life transitions. Financial terms were not disclosed. Mavida will continue operating as an independent company under its own leadership, with WPS Chief Growth Officer Rochelle Myers also stepping in as Mavida's new president, and the company announced plans to expand into new states.

Why It Matters

For a femtech sector that has spent years fighting to prove reproductive and sexual health belong inside mainstream healthcare budgets, a legacy insurer buying a women's mental-health startup is a meaningful reimbursement signal. Insurer ownership points toward a future where cycle-, fertility-, and menopause-linked mental health care is paid for as covered benefit rather than out-of-pocket wellness — the same shift Clue achieved in May when German insurer SDK became the first to cover a period tracker. It also reflects payer recognition that the perimenopause and postpartum mental-health gaps are expensive problems worth owning. For founders, it's another data point that strategic acquisition by incumbents — not just venture exits — is becoming a viable femtech endgame.

Founded in 2023 by reproductive psychiatrist Dr. Sarah Oreck and health-tech leader Emma Sugerman, Mavida delivers mental-health support tied to the hormonal arc of women's lives: PMDD, fertility challenges, pregnancy and pregnancy loss, postpartum depression and anxiety, and perimenopause and menopause. "Women's mental health is inextricably tied to their hormones, and yet for too long, that connection has been dismissed or ignored," Oreck said in announcing the deal — framing the acquisition as validation of a hormone-anchored model of women's behavioral health.

WPS described the purchase as the first in a planned series of targeted investments and part of a broader revenue-diversification strategy. Femtech Insider and Behavioral Health Business both noted the deal slots into a clear 2026 pattern of payers treating women's health as a strategic acquisition category, alongside Delta Dental's Midi Health partnership and Securian Canada's investment in June Health.

Sources

Update — 2026-06-30

Initial entry — story first created.